Cargando…
Biguanide is a modifiable pharmacophore for recruitment of endogenous Zn(2+) to inhibit cysteinyl cathepsins: review and implications
ABSTRACT: Excessive activities of cysteinyl cathepsins (CysCts) contribute to the progress of many diseases; however, therapeutic inhibition has been problematic. Zn(2+) is a natural inhibitor of proteases with CysHis dyads or CysHis(Xaa) triads. Biguanide forms bidentate metal complexes through the...
Autor principal: | Lockwood, Thomas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647370/ https://www.ncbi.nlm.nih.gov/pubmed/31044334 http://dx.doi.org/10.1007/s10534-019-00197-1 |
Ejemplares similares
-
Cysteinyl Cathepsins: Multifunctional Enzymes in Cardiovascular Disease
por: Li, Xiang, et al.
Publicado: (2012) -
Can cysteinyl cathepsin activity control diet-induced NAFLD?
por: Yu, Chenglin, et al.
Publicado: (2020) -
Differential Roles of Cysteinyl Cathepsins in TGF-β Signaling and Tissue Fibrosis
por: Zhang, Xian, et al.
Publicado: (2019) -
Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications
por: Cheng, Xian Wu, et al.
Publicado: (2023) -
Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth
por: Hébert, Audrey, et al.
Publicado: (2021)